Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

LMX1B transactivation and expression in nail-patella syndrome.

Dreyer SD, Morello R, German MS, Zabel B, Winterpacht A, Lunstrum GP, Horton WA, Oberg KC, Lee B.

Hum Mol Genet. 2000 Apr 12;9(7):1067-74.

PMID:
10767331
2.

Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome.

Chen H, Lun Y, Ovchinnikov D, Kokubo H, Oberg KC, Pepicelli CV, Gan L, Lee B, Johnson RL.

Nat Genet. 1998 May;19(1):51-5.

PMID:
9590288
3.

Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome.

Vollrath D, Jaramillo-Babb VL, Clough MV, McIntosh I, Scott KM, Lichter PR, Richards JE.

Hum Mol Genet. 1998 Jul;7(7):1091-8. Erratum in: Hum Mol Genet 1998 Aug;7(8):1333.

PMID:
9618165
4.

A neurological phenotype in nail patella syndrome (NPS) patients illuminated by studies of murine Lmx1b expression.

Dunston JA, Reimschisel T, Ding YQ, Sweeney E, Johnson RL, Chen ZF, McIntosh I.

Eur J Hum Genet. 2005 Mar;13(3):330-5.

5.
6.

Identification of entire LMX1B gene deletions in nail patella syndrome: evidence for haploinsufficiency as the main pathogenic mechanism underlying dominant inheritance in man.

Bongers EM, de Wijs IJ, Marcelis C, Hoefsloot LH, Knoers NV.

Eur J Hum Genet. 2008 Oct;16(10):1240-4. doi: 10.1038/ejhg.2008.83. Epub 2008 Apr 16.

7.

Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome.

Dreyer SD, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W, Johnson RL, Lee B.

Nat Genet. 1998 May;19(1):47-50.

PMID:
9590287
9.

Functional characterization of LMX1B mutations associated with nail-patella syndrome.

Sato U, Kitanaka S, Sekine T, Takahashi S, Ashida A, Igarashi T.

Pediatr Res. 2005 Jun;57(6):783-8. Epub 2005 Mar 17.

PMID:
15774843
10.

Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy.

Bongers EM, Huysmans FT, Levtchenko E, de Rooy JW, Blickman JG, Admiraal RJ, Huygen PL, Cruysberg JR, Toolens PA, Prins JB, Krabbe PF, Borm GF, Schoots J, van Bokhoven H, van Remortele AM, Hoefsloot LH, van Kampen A, Knoers NV.

Eur J Hum Genet. 2005 Aug;13(8):935-46.

11.

Nail-patella syndrome. Overview on clinical and molecular findings.

Bongers EM, Gubler MC, Knoers NV.

Pediatr Nephrol. 2002 Sep;17(9):703-12. Epub 2002 Jul 30. Review.

PMID:
12215822
12.

[From gene to disease; the nail-patella syndrome and the LMX1B gene].

Bongers EM, Knoers NV.

Ned Tijdschr Geneeskd. 2003 Jan 11;147(2):67-9. Review. Dutch.

PMID:
12602071
13.

Nail-patella syndrome: identification of mutations in the LMX1B gene in Dutch families.

Knoers NV, Bongers EM, van Beersum SE, Lommen EJ, van Bokhoven H, Hol FA.

J Am Soc Nephrol. 2000 Sep;11(9):1762-6.

14.

Twenty-two novel LMX1B mutations identified in nail patella syndrome (NPS) patients.

Hamlington JD, Jones C, McIntosh I.

Hum Mutat. 2001 Nov;18(5):458.

PMID:
11668639
15.

A novel mutation in LMX1B gene causes nail-patella syndrome in a large Chinese family.

Lin Y, Zhao J, Chen S, Zeng X, Du Q, Yang Y, Lu F, Pu Y, Yang Z.

Bone. 2008 Sep;43(3):591-5. doi: 10.1016/j.bone.2008.04.025. Epub 2008 May 16.

PMID:
18595794
16.

Identification of LMX1B gene point mutations in italian patients affected with Nail-Patella syndrome.

Seri M, Melchionda S, Dreyer S, Marini M, Carella M, Cusano R, Piemontese MR, Caroli F, Silengo M, Zelante L, Romeo G, Ravazzolo R, Gasparini P, Lee B.

Int J Mol Med. 1999 Sep;4(3):285-90.

PMID:
10425280
17.

Confirmation of CLIM2/LMX1B interaction by yeast two-hybrid screening and analysis of its involvement in nail-patella syndrome.

Marini M, Bongers EM, Cusano R, Di Duca M, Seri M, Knoers NV, Ravazzolo R.

Int J Mol Med. 2003 Jul;12(1):79-82.

PMID:
12792813
18.

The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes.

Rohr C, Prestel J, Heidet L, Hosser H, Kriz W, Johnson RL, Antignac C, Witzgall R.

J Clin Invest. 2002 Apr;109(8):1073-82.

19.

In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys.

Heidet L, Bongers EM, Sich M, Zhang SY, Loirat C, Meyrier A, Broyer M, Landthaler G, Faller B, Sado Y, Knoers NV, Gubler MC.

Am J Pathol. 2003 Jul;163(1):145-55.

20.

How are podocytes affected in nail-patella syndrome?

Witzgall R.

Pediatr Nephrol. 2008 Jul;23(7):1017-20. doi: 10.1007/s00467-007-0714-9. Epub 2008 Feb 6.

Supplemental Content

Support Center